sec filing
PR
NASDAQ · PRLD
Prelude Therapeutics Incorporated
Healthcare · Biotechnology
$6.34
Down-$0.87 (-13.72%)
Updated Aug 28, 2026, 9:57 PM
SID Score
6.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 89.12M
- P/E ratio
- -0.99
- Dividend yield
- 0.00%
- 52-week range
- $0.98 – $6.83
- Volume
- 364.18K
- Avg. volume
- 1.38M
Price performance
PRLD price history
1M range · 21 trading sessions · Daily adjusted prices
PRLD closed at $6.34 after 21 trading sessions, up 25.54% for the selected period.
- Last close
- $6.34
- Period change
- +25.54%
- Period low
- $4.39
- Period high
- $6.63
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | $6.48 | $6.61 | $6.21 | $6.34 | 364.18K |
| Aug 26, 2026 | $6.61 | $6.71 | $6.3701 | $6.56 | 466.28K |
| Aug 25, 2026 | $6.57 | $6.695 | $6.31 | $6.59 | 415.48K |
| Aug 24, 2026 | $6.64 | $6.83 | $6.115 | $6.47 | 515.72K |
| Aug 21, 2026 | $6.56 | $6.8162 | $6.40 | $6.63 | 519.21K |
| Aug 20, 2026 | $5.70 | $6.6496 | $5.70 | $6.50 | 2.44M |
| Aug 19, 2026 | $5.84 | $5.90 | $5.66 | $5.78 | 421.55K |
| Aug 18, 2026 | $5.62 | $5.78 | $5.485 | $5.75 | 268.55K |
| Aug 17, 2026 | $5.57 | $5.86 | $5.45 | $5.63 | 265.43K |
| Aug 14, 2026 | $5.45 | $5.61 | $5.15 | $5.55 | 452.14K |
| Aug 13, 2026 | $5.77 | $5.91 | $5.21 | $5.36 | 888.27K |
| Aug 12, 2026 | $5.39 | $5.8973 | $5.39 | $5.73 | 623.88K |
| Aug 11, 2026 | $4.95 | $5.85 | $4.83 | $5.32 | 698.44K |
| Aug 10, 2026 | $4.91 | $5.00 | $4.81 | $4.83 | 217.17K |
| Aug 7, 2026 | $4.74 | $4.915 | $4.63 | $4.90 | 165.7K |
| Aug 6, 2026 | $4.47 | $4.75 | $4.47 | $4.68 | 242.34K |
| Aug 5, 2026 | $4.51 | $4.595 | $4.37 | $4.54 | 158.28K |
| Aug 4, 2026 | $4.41 | $4.58 | $4.405 | $4.52 | 218.84K |
| Aug 3, 2026 | $4.65 | $4.65 | $4.35 | $4.39 | 288.74K |
| Jul 31, 2026 | $5.03 | $5.15 | $4.57 | $4.60 | 292.74K |
| Jul 30, 2026 | $4.71 | $5.13 | $4.71 | $5.05 | 329.78K |
Latest PRLD news
The latest Smart Investors Daily articles mentioning PRLD.
Stock researchResearch & News · SEC Filings
Loading stock research…